3.2. Synthesis and characterization of dihydroxydiamides 3a-d
3.2.1. (S,S)-N,N-bis(2-hydroxy-1-isopropyl)-2-(fluoren-9-ylidene) malonamide (3a)
To a solution of diethyl fluoren-9-ylidene malonate 2a (1.0 g, 3.10 mmol) in CH3OH (10 mL) was added a NaOH solution (10 mL, 2.0 M). The mixture was refluxed for 8 h, then the methanol was removed invacuo. The residue was cooled to 0 °C and acidified with aqueous HCl (6 M). The acidified mixture was extracted with ethyl acetate (10 mL × 3), and the combined organic phase was washed with brine, dried over Na2SO4 and evaporated to give yellow solid, which was directly added to a solution of CH2Cl2 (20 mL) and DMF (0.1 mL), subsequently at 0 °C oxalyl chloride (1.20 g, 9.44 mmol) was slowly injected and then the mixture stirred for 3 h. Removal of the excess oxalyl chloride in vacuo afforded the diacyl dichloride as a yellow solid. The diacyl dichloride in CH2Cl2 (20 mL) was added dropwise to a solution of L-valinol (0.75 g, 7.28 mmol) and Et3N (4 mL, 28.9 mmol) in CH2Cl2 (20 mL) at 0 °C and stirred at room temperature for 4 h. The reaction mixture was washed with water (5 mL × 2). The organic layer was dried over Na2SO4 and concentrated to give crude solid. Purification by silica gel column chromatography (70% ethyl acetate in petroleum ether) afforded the dihydroxydiamide 3a. Yield: 1.16 g (86%) as a yellow solid. m.p. 238.0~239.5 °C; [α]D25 = +66.0 (c = 0.10, CH2Cl2). IR (cm-1): 3252, 3061, 2962, 1633, 1540, 1449, 1317, 1057, 725; 1H-NMR (DMSO): δ 8.22 (d, J = 8.88 Hz, 2H, NH), 7.83 (dd, J = 7.50, 11.70 Hz, 4H, ArH), 7.43-7.38 (m, 2H, ArH), 7.27-7.22 (m, 2H, ArH), 4.60(s, 2H, OH), 3.89-3.85 (m, 2H, CHNH), 3.54-3.41 (m, 4H, CH2O), 1.99-1.93 (m, 2H, CHMe2), 0.91 (d, J = 6.87 Hz, 6H, CH3), 0.85 (d, J = 6.87 Hz, 6H, CH3); 13C-NMR (DMSO): δ 165.2, 139.9, 135.7, 134.5, 131.7, 129.5, 127.5, 124.9, 120.0, 61.1, 56.1, 28.3, 19.9, 17.6; Anal. Calcd. for C26H32N2O4 (436.55): C 71.53, H 7.39, N 6.42; Found: C 71.79, H 7.65, N 6.33.
3.2.2. (S,S)-N,N-bis(2-hydroxy-1-isobutyl)-2-(fluoren-9-ylidene) malonamide (3b)
Prepared according to procedure 3.2.1. Yield: 1.20 g (84%). m.p. 223~224.5 °C; [α]D25 = +84.4 (c = 0.15, CH2Cl2); IR (cm-1): 3254, 3060, 2956, 2870, 1638, 1542, 1449, 1385, 1367, 1320, 1064, 774, 725; 1H-NMR (DMSO): δ 8.21(d, J = 11.70 Hz, 2H, NH), 7.84 (dd, J = 7.35, 12.60 Hz, 4H, ArH), 7.43-7.38 (m, 2H, ArH), 7.26-7.21 (m, 2H, ArH), 4.81(s, 2H, OH), 4.05-4.04 (m, 2H, CHNH), 3.50 (dd, J = 5.10, 10.20 Hz, 2H, CH2O), 3.35-3.27(m, 2H, CH2O), 1.70-1.61(m, 2H, CHCH2), 1.43-1.29 (m, 4H, CH2), 0.92 (dd, J = 6.48 Hz, 6H, CH3), 0.88 (dd, J = 6.60 Hz, 6H, CH3); 13C-NMR (DMSO): δ 164.9, 139.9, 135.7, 134.4, 131.8, 129.5, 127.3, 124.8, 120.1, 63.7, 49.3, 24.1, 23.8, 21.8; Anal. Calcd. for C28H36N2O4 (464.60): C 72.39, H 7.81, N 6.03; Found: C 72.54, H 7.68, N 6.31.
3.2.3. (S,S)-N,N-bis(2-hydroxy-1-benzyl)-2-(fluoren-9-ylidene) malonamide (3c)
Prepared according to procedure 3.2.1. Yield: 1.45 g (88 %). m.p. 197.5~198.5 °C; [α]D25 = +23.0 (c = 0.45, CH2Cl2). IR (cm-1): 3423, 1637, 1627, 1537, 1449, 1035, 775, 727, 701; 1H-NMR (DMSO): δ 8.43-8.41(d, J = 8.40 Hz, 2H, NH), 7.78 (d, J = 7.50 Hz, 2H, ArH), 7.48-7.45(d, J = 7.80 Hz, 2H, ArH), 7.37-7.17(m, 10H, ArH), 7.05(t, J = 7.50 Hz, 2H, ArH), 4.92 (t, J = 5.25 Hz, 2H), 4.24-4.19 (m, 2H, CHNH), 3.52-3.45 (m, 2H, CH2O), 3.42-3.35(m, 2H, CH2O), 2.94 (dd, J = 6.09, 13.50 Hz, 2H, CH2Ph), 2.74 (dd, J = 7.80, 13.80 Hz, 2H, CH2Ph); 13C-NMR (DMSO): δ 164.8, 139.9, 139.0, 135.5, 133.8, 132.5, 129.4, 129.3, 128.4, 127.5, 126.3, 124.7, 119.9, 62.2, 53.0, 36.6; Anal. Calcd. for C34H32N2O4 (532.63): C 76.67, H 6.06, N 5.26; Found: C 76.62, H 6.20, N 5.37.
3.2.4. (S,S)-N,N-bis(2-hydroxy-1-phenyl)-2-(fluoren-9-ylidene) malonamide (3d)
Prepared according to procedure 3.2.1. Yield: 1.33g (85%). m.p. 238~239 °C; [α]D25 = +40.0 (c = 0.1, CH2Cl2). IR (cm-1): 3436, 1639, 1532, 1449, 1040, 720, 700; 1H-NMR (DMSO): δ 9.05 (d, J = 8.10 Hz, 2H, NH), 7.81 (d, J = 7.50 Hz, 2H, ArH), 7.45-7.30 (m, 12H, ArH), 7.01-6.96 (m, 2H, ArH), 5.08 (dd, J = 7.50, 13.50 Hz, 2H, CHNH), 5.02 (t, J = 5.10 Hz, 2H, OH), 3.71-3.65 (m, 4H, CH2O); 13C-NMR (DMSO): δ 164.5, 140.3, 139.9, 135.4, 133.6, 132.6, 129.5, 128.3, 127.4, 127.4, 127.2, 124.8, 119.9, 64.5, 55.6; Anal. Calcd. for C32H28N2O4 (504.58): C 76.17, H 5.59, N 5.55; Found: C 76.01, H 5.70, N 5.27.
3.3. The synthesis and characterization of bis(oxazoline) ligands 1a-d
3.3.1. Bis[(S)-4-iso-propyloxazoline-2-yl]-2-(fluoren-9-yl)-ethene (1a)
MsCl (0.30 g, 2.63 mmol) was slowly added to an ice-cooled solution of the dihydroxydiamide 3a (0.50 g, 1.15 mmol) and Et3N (4 mL, 28 mmol) in CH2Cl2 (20 mL). The mixture was allowed to warm to room temperature and stirred for 12 h. The mixture was washed with water (2 × 5 mL). The organic layer was dried over anhydrous Na2SO4 and concentrated to drynessinvacuo, the residue was purified by flash chromatography on silica gel (ethyl acetate/petroleum ether, 1/1, v/v) to afford 1a as a yellow solid. Yield: 0.36 g (78%); m.p. 163~164.5 °C; [α]D25 = -88.6 (c = 0.50, CH2Cl2). IR (cm-1): 2956, 2874, 1652, 1609, 1481, 1447, 1370, 1016, 946, 785, 732; 1H-NMR (CDCl3): δ 7.73 (d, J = 7.46 Hz, 2H), 7.58 (d, J = 7.50Hz, 2H), 7.35-7.30 (m, 2H, ArH), 7.21-7.15 (m, 2H, ArH), 4.51-4.46 (m, 2H, CHN=), 4.26-4.15 (m, 4H, CH2O), 1.96 (t, J = 6.63 Hz, 2H, CHMe), 1.06 (d, J = 6.75 Hz, 6H, CH3), 0.99 (d, J = 6.75 Hz, 6H, CH3); 13C-NMR (CDCl3): δ 161.3, 144.8, 141.5, 136.5, 130.2, 127.2, 125.9, 119.5, 115.1, 73.4, 70.3, 32.7, 19.1, 18.3; Anal. Calcd. for C26H28N2O2 (400.51): C 77.97, H 7.05, N 6.99; Found: C 77.98, H 7.24, N 7.07.
3.3.2. Bis[(S)-4-iso-butyloxazoline-2-yl]-2-(fluoren-9-yl)-ethene (1b)
Prepared according to procedure 3.3.1, starting from 3b (0.5 g, 1.08 mmol) and MsCl (0.28 g, 2.46 mmol) in CH2Cl2 (15.0 mL); yellow solid; yield: 0.39 g (84 %); m.p. 67.0~68.5 °C; [α]D25 = -88.8 (c = 0.25, CH2Cl2). IR (cm-1): 2955, 1648, 1468, 1449, 1368, 1276, 1152, 1040, 1003, 938, 786, 728; 1H-NMR (CDCl3): δ 7.75 (d, J = 7.80 Hz, 2H, ArH), 7.58 (d, J = 7.50 Hz, 2H, ArH), 7.36-7.30 (m, 2H, ArH), 7.21-7.16 (m, 2H, ArH), 4.59-4.53 (dd, J = 7.80, 9.60 Hz, 2H, CH2O), 4.48-4.40 (m, 2H, CHN=), 4.05 (t, J = 7.80 Hz, 2H, CH2O), 1.90-1.78 (m, 4H, CH2), 1.52-1.41 (m, 2H, CHMe2), 0.99 (t, J = 6.0 Hz, 12H, CH3); 13C-NMR (CDCl3): δ 161.1, 144.8, 141.5, 136.4, 130.2, 127.1, 125.9, 119.4, 114.9, 73.2, 70.3, 65.6, 44.9, 25.3, 22.6, 22.6; Anal. Calcd. for C28H32N2O2 (428.57): C 78.47, H 7.53, N 6.54. Found: C 78.66, H 7.75, N 6.57.
3.3.3. Bis[(S)-4-benzyloxazoline-2-yl]-2-(fluoren-9-yl)-ethene (1c)
Prepared according to the procedure 3.3.1, starting from 3c (0.50 g, 0.94 mmol) and MsCl (0.25 g, 2.19 mmol) in CH2Cl2 (15.0 mL); yellow solid; yield: 0.36g (77%); m.p. 120.0~122.0 °C; [α]D25 = -108.8 (c = 0.25, CH2Cl2). IR (cm-1): 2957,1649, 1614, 1496, 1449, 1309, 1228, 1147, 1018, 977, 783, 728, 700; 1H-NMR (CDCl3): δ 7.61 (d, J = 7.84 Hz, 2H), 7.56 (d, J = 7.23 Hz, 2H, ArH), 7.35-7.21 (m, 12H, ArH), 7.16-7.11(m, 2H), 4.79-4.68 (m, 4H, CHN=), 4.45(t, J = 8.74 Hz, 2H, CH2O), 4.18 (t, J = 8.44 Hz, 2H, CH2O), 3.32 (dd, J = 5.18, 13.81Hz, 2H, CH2Ph), 2.90 (dd, J = 8.60, 13.80 Hz, 2H, CH2Ph); 13C-NMR (CDCl3): δ 162.0, 145.4, 141.6, 137.6, 136.4, 130.4, 129.4, 128.6, 127.3, 126.6, 126.0, 119.5, 114.4, 72.0, 68.5, 41.1; Anal. Calcd. for C34H28N2O2 (496.60): C 82.23, H 5.68, N 5.64. Found: C 82.47, H 5.77, N 5.47.
3.3.4. Bis[(S)-4-phenyloxazoline-2-yl]-2-(fluoren-9-yl)-ethene (1d)
Prepared according to the procedure 3.3.1, starting from 3d (0.50 g, 0.99 mmol) and MsCl (0.25 g, 2.19 mmol) in CH2Cl2 (15.0 mL); yellow solid; yield: 0.35 g (75 %); m.p. 167.5~168.5 °C; [α]D25 = -104.4 (c = 0.45, CH2Cl2); IR (cm-1): 1653, 1448, 1356, 1268, 1204, 1145, 1017, 957, 938, 786, 735, 701; 1H-NMR (CDCl3): δ 7.79 (d, J = 7.83 Hz, 2H, ArH), 7.60 (d, J = 7.47 Hz, 2H, ArH), 7.42-7.26 (m, 12H, ArH), 7.18-7.15(m, 2H, ArH), 5.57 (dd, J = 8.64, 10.26 Hz, 2H, CHN=), 4.90 (dd, J = 8.61, 10.32 Hz, 2H, CH2O), 4.38 (t, J = 8.61 Hz, 2H, CH2O); 13C-NMR (CDCl3): δ 162.9, 146.1, 141.7, 141.6, 136.40, 130.6, 128.8, 127.7, 127.4, 126.9, 126.2, 119.6, 114.0, 74.8, 70.7; Anal. Calcd. for C32H24N2O2 (468.55): C 82.03, H 5.16, N 5.98; Found: C 82.22, H 5.27, N 5.89.
3.4. General procedure for the asymmetric F-C alkylation of indoles with alkylidenemalonates
Cu(OTf)2 (0.025 mmol) was added to a Schlenk tube, followed by ligand 1d (0.0275 mmol) in iso-butanol (1.0 mL) under N2, the solution was stirred for 1.5 h at room temperature, a mixture of the appropriate diethyl arylidenemalonate (0.25 mmol) in the above solvent (1.0 mL) was added. After stirring for 30 min the indole (0.25 mmol) was added. After stirring for 24~48 h at room temperature, the solution was concentrated in vacuo, The crude product was purified by flash column chromatography on silica gel (eluted with ethyl acetate-petroleum ether, 1/5, v/v) to afford the (S)-ethyl-2-ethoxycarbonyl-3-(3-indolyl)-3-arylpropanoate as a white solid in high yield; the enantiomeric excesses of all adducts were determined by HPLC with a chiral column (Daicel Chiralcel OD-H; hexane-isopropyl alcohol 90:10; flow rate 0.8 mL/min; 254 nm).
3.4.1. (S)–Ethyl 2–ethoxycarbonyl–3–(3–indolyl)–3–phenyl propanoate
Prepared according to the general procedure from diethyl benzylidenemalonate and indole to provide the pure product as a white solid; m.p. 172-176 °C; [α]D25 = + 33.6 (c = 0.45, CH2Cl2); 1H-NMR (CDCl3): δ 8.04 (brs, 1H, NH), 7.55 (d, J = 8.0 Hz, 1H, ArH), 7.09-7.37 (m, 8H, ArH), 7.00-7.07(m, 1H, ArH), 5.07 (d, J = 11.7 Hz, 1H, CH), 4.28 (d, J = 11.7 Hz, 1H, CH), 3.93-4.04 (m, 4H, OCH2), 0.96-1.03 (m, 6H, CH3); 13C-NMR (CDCl3): δ 168.1, 167.9, 141.4, 136.2, 128.4, 128.2, 126.8, 126.7, 122.3, 120.9, 119.5, 119.4, 117.0, 111.0, 61.5, 61.4, 58.4, 42.9, 13.8. HPLC analysis: tr (minor) = 12.43 min, tr (major) = 15.14 min, 78% ee.
3.4.2. (S)–Ethyl 2–ethoxycarbonyl–3–(3–indolyl)–3–(p-methylphenyl) propanoate
Prepared according to the general procedure from diethyl p-methylbenzylidenemalonate and indole to provide the pure product as a white solid; m.p. 137-139 °C; [α]D25 = +10.5 (c = 0.50, CH2Cl2); 1H-NMR (CDCl3): δ 7.97 (s, 1H, NH), 7.54 (d, J = 7.80 Hz, 1H, ArH), 7.29-7.23 (m, 3H, ArH), 7.16-7.09 (m, 2H, ArH), 7.04-6.99 (m, 2H, ArH), 5.03 (d, J = 11.70 Hz, 1H, CH), 4.26 (d, J = 11.70 Hz, 1H, CH), 2.24 (s, 3H, CH3), 1.03 (t, J = 6.90 Hz, 3H, CH3), 0.97 (t, J = 6.90 Hz, 3H, CH3). 13C-NMR (CDCl3): δ 168.1, 167.9, 138.4, 136.2, 136.2, 129.0, 128.0, 126.7, 122.2, 120.8, 119.5, 119.5, 117.3, 110.9, 61.4, 61.4, 58.4, 42.4, 21.0, 13.8. HPLC analysis: tr (minor) = 14.99 min, tr (major) = 16.28 min, 37% ee.
3.4.3. (S)–Ethyl 2–ethoxycarbonyl–3–(3–indolyl)–3–(p-fluorophenyl)) propanoate
Prepared according to the general procedure from diethyl p-fluorobenzylidenemalonate and indole to provide the pure product as a white solid; m.p. 132.5-134 °C; [α]D25 = +22.0 (c = 0.50, CH2Cl2); 1H-NMR (CDCl3): δ 8.03 (s, 1H, NH), 7.62 (d, J = 8.10 Hz, 1H, ArH), 7.32-7.05 (m, 5H, ArH), 6.98 (d, J = 2.76 Hz, 1H, ArH), 6.84 (dd, J = 3.90, 5.10 Hz, 1H, ArH), 5.38 (d, J = 11.40 Hz, 1H, CH), 4.29 (d, J = 11.40 Hz, 1H, CH), 4.10(q, J = 7.20 Hz, 2H, OCH2), 3.93 (q, J = 6.99 Hz, 2H, OCH2), 1.13 (t, J = 6.84 Hz, 3H, CH3), 0.91 (t, J = 7.08 Hz, 3H, CH3); 13C-NMR (CDCl3): δ 168.0, 167.8, 161.7, 137.5, 137.6, 136.4, 129.9, 129.8, 126.6, 122.5, 120.9, 119.8, 119.4, 116.9, 115.5, 115.2, 111.2, 61.8, 61.7, 58.5, 42.5, 13.9, 13.8. HPLC analysis: tr (minor) = 15.57 min, tr (major) = 18.19 min, 31% ee.
3.4.4. (S)–Ethyl 2–ethoxycarbonyl–3–(3–indolyl)–3–(m-bromophenyl) propanoate
Prepared according to the general procedure from diethyl m-bromobenzylidenemalonate and indole to provide the pure product as a white solid; m.p. 123-124 °C; [α]D25 = +24.0 (c = 0.20, CH2Cl2); 1H-NMR (CDCl3): δ 8.05(s, 1H, NH), 7.50 (dd, 2H, ArH), 7.32-7.02 (m, 7H, ArH), 5.04 (d, J = 12.0 Hz, 1H, CH),4.23 (d, J = 12.0 Hz, 1H), 4.05-3.98 (m, 4H, OCH2), 1.08-0.96 (m, 6H, CH3); 13C-NMR (CDCl3): δ 167.8, 167.7, 146.9, 146.3, 131.3, 129.9, 127.0, 126.5, 122.4, 122.4, 121.1, 119.6, 119.1, 116.1, 111.2, 61.7, 58.2, 42.4, 13.9, 13.7. HPLC analysis: tr(minor) = 15.31 min, tr (major) = 20.64 min), 52% ee.
3.4.5. (S)–Ethyl 2–ethoxycarbonyl–3–(3–indolyl)–3–(o-chlorophenyl) propanoate
Prepared according to the general procedure from diethyl o-chlorobenzylidenemalonate and indole to provide the pure product as a white solid; m.p. 125-127 °C; [α]D25 = +22.6 (c = 0.50, CH2Cl2); 1H-NMR (CDCl3): δ 8.15 (s, 1H, NH), 7.68 (d, J = 7.80 Hz, 1H, ArH), 7.40-7.23(m, 3H, ArH), 7.14-7.04 (m, 5H, ArH), 5.66 (d, J = 11.70 Hz, 1H, CH), 4.40 (d, J = 11.70 Hz, 1H, CH), 4.04-3.92 (m, 4H, OCH2), 1.01 (t, J = 6.90 Hz, 3H, CH3), 0.94 (t, J = 6.90 Hz, 3H, CH3); 13C-NMR (CDCl3): δ 168.1, 167.7, 139.3, 136.2, 134.2, 129.9, 129.0, 128.1, 126.9, 126.8, 122.3, 122.2, 119.6, 119.7, 115.8, 111.3, 61.7, 57.8, 38.9, 13.8, 13.7. HPLC analysis: tr (minor) = 15.88 min, tr (major) = 20.63 min, 88% ee.
3.4.6. (S)–Ethyl 2–ethoxycarbonyl–3–(3–indolyl)–3–(o-methylphenyl) propanoate
Prepared according to the general procedure from diethyl o-methylbenzylidenemalonate and indole to provide the pure product as a white solid; m.p. 94-95 °C; [α]D25 = +1.5 (c = 0.20, CH2Cl2). 1H-NMR (CDCl3): δ 7.87 (s, 1H, NH), 7.82 (d, J = 7.50 Hz, 2H, ArH), 7.64-7.62 (m, 1H, ArH), 7.37-7.25 (m, 3H), 7.20-7.00 (m, 3H, ArH), 5.31(d, J = 12.0 Hz, 1H, CH), 4.33(d, J = 12.0 Hz, 1H, CH), 4.00-3.86 (m, 4H, OCH2), 1.01-0.85 (m, 6H, CH3); 13C-NMR (75MHz, CDCl3): δ 168.4, 167.9, 140.1, 136.3, 135.9, 130.7, 126.8, 126.4, 126.3, 126.0, 122.3, 122.1, 119.5, 119.3, 116.5, 110.9, 61.4, 61.3, 58.5, 38.0, 19.9, 13.7, 13.6. HPLC analysis: tr (minor) = 12.21 min, tr (major) = 15.39 min, 15% ee.
3.4.7. (S)-Ethyl 2-ethoxycarbonyl-3-[3-(5-methoxyindolyl)]-3-phenylpropanoate
Prepared according to the general procedure from diethyl benzylidenemalonate and 5-methoxyindole to provide the pure product as a white solid; m.p. 143-145 °C; [α]D25 = +6.0 (c = 0.20, CH2Cl2); 1H-NMR (CDCl3): δ 7.91(s, 1H, NH), 7.38-7.34 (m, 2H, ArH), 7.25-7.11 (m, 4H, ArH), 6.96 (d, J = 2.40Hz, 1H, ArH), 6.78 (dd, J = 2.40 Hz, 9.0 Hz, ArH), 5.01 (d, J = 12.0 Hz, CH), 4.25 (d, J = 12.0 Hz, CH), 4.05-3.94 (m, 4H, 2×CH2), 3.78 (s, 3H, OCH3), 1.00 (t, J = 7.20 Hz, 6H, 2×CH3). 13C-NMR (CDCl3): δ 168.1, 167.6, 140.8, 139.6, 131.5, 128.7, 127.4, 127.3, 126.7, 120.8, 111.7, 101.3, 61.6, 61.5, 58.4, 55.8, 42.5, 13.8. HPLC analysis: tr (minor) = 20.40 min, tr (major) = 27.86 min, 41% ee.
3.4.8. (S)-Ethyl 2-ethoxycarbonyl-3-[3-(5-methylindolyl)]-3-phenylpropanoate
Prepared according to the general procedure from diethyl benzylidenemalonate and 5-methylindole to provide the pure product as a white solid; m.p. 176.5-178 °C; [α]D25 = +24.0 (c = 0.50, CH2Cl2); 1H-NMR (CDCl3): δ 7.89 (s, 1H, NH), 7.38-7.33 (m, 3 H, ArH), 7.26-7.13 (m, 5H, ArH), 5.04 (d, J = 11.70 Hz, 1H, CH), 4.26 (d, J = 11.70 Hz, 1H, CH), 4.03-3.93(m, 4H, 2×CH2), 2.38 (s, 3H, CH3), 1.02-0.97 (m, 6H, 2×CH3); 13C-NMR (CDCl3): δ 167.9, 167.8, 141.3, 134.3, 128.5, 128.2, 128.0, 126.7, 126.6, 123.7, 120.8, 118.7, 116.3, 110.4, 76.6, 61.3, 61.2, 58.3, 42.6, 21.5, 13.5, 13.6. HPLC analysis: tr (minor) = 13.28 min, tr (major) = 16.45 min, 47% ee.
3.4.9. (S)-Ethyl 2-ethoxycarbonyl-3-[3-(5-chloroindolyl)]-3-phenylpropanoate
Prepared according to the general procedure from diethyl benzylidenemalonate and 5-chloroindole to provide the pure product as a white solid; m.p. 190-192 °C; [α]D25 = -6.0 (c = 0.20, CH2Cl2); 1H-NMR (CDCl3): δ 8.03 (s, 1H, NH), 7.51 (d, J = 1.80 Hz, 1H, ArH), 7.36-7.06 (m, 7H, ArH), 6.91 (d, J = 2.49 Hz, 1H, ArH), 5.00 (d, J = 12.0 Hz, 1H, CH), 1.03-0.98 (m, 6 H, 2×CH3); 13C-NMR (CDCl3): δ 167.9, 167.8, 141.1, 134.9, 128.6, 128.5, 128.1, 127.1, 125.4, 122.3, 122.1, 116.8, 113.1, 112.6, 77.4, 61.6, 61.5, 58.6, 42.7, 13.9. HPLC analysis: tr (minor) = 14.88 min, tr (major) = 20.25 min, 45% ee.
3.4.10. (S)-Ethyl 2-ethoxycarbonyl-3-[3-(6-chloroindolyl)]-3-phenylpropanoate
Prepared according to the general procedure from diethyl benzylidenemalonate and 6-chloroindole to provide the pure product as a white solid; m.p. 203-205 °C; [α]D25 = +20.0 (c = 0.25, CH2Cl2); 1H-NMR (CDCl3): δ 8.02 (s, 1H, NH), 7.42 (d, J = 8.40 Hz, 1H, ArH), 7.35-7.15 (m, 7H, ArH), 5.02 (d, J = 11.70 Hz, 1H, CH), 4.25 (d, J = 12.0 Hz, 1H, CH), 4.04-3.94 (m, 4 H, 2×CH2), 1.00 (t, J = 7.20 Hz, 2×CH3); 13C-NMR (CDCl3): δ 167.9, 167.7, 141.1, 136.5, 128.4, 128.2, 128.1, 126.9, 125.3, 121.5, 120.3, 120.2, 117.2, 110.9, 77.4, 61.5, 61.4, 58.3, 42.7, 13.7. HPLC analysis: tr(minor) = 14.93 min, tr (major) = 17.95 min, 10% ee.